Alucent Biomedical Inc. announced that it has enrolled the first patient in ACTIVATE II, an Australia-based first-in-human clinical trial to evaluate the safety and efficacy of AlucentNVS, the company’s natural vascular scaffolding device. According to the company, the ACTIVATE II trial will enroll up to 50 patients at up to
Koya Medical announced the United States commercial availability of its Dayspring active compression system for the treatment of lymphedema and venous diseases in the lower extremities. The company also announced that the Centers for Medicare & Medicaid Services (CMS) issued three new billing codes in accordance with the Healthcare Common
AngioDynamics, Inc. announced the launch of a new clinical study assessing the use of the company’s Auryon atherectomy system in the treatment of calcified lesions in below-the-knee (BTK) arteries. The company announced the commercial launch of the Auryon system in Sep. 2020. The investigator-initiated Auryon BTK study will be conducted
Merit Medical Systems, Inc. announced the enrollment of the first patient in the company’s prospective, observational study of EmboCube embolization gelatin to control bleeding or hemorrhage. The EmboCube Embolization Gelatin study is designed to enroll 100 patients across multiple centers in Australia and France. The company advised that EmboCube is
Vesalio announced that data on the use of the company’s NeVa thrombectomy device were published by Arsida Bajrami, MD, et al in Interventional Neuroradiology. The company stated that the NeVa platform is designed to consistently achieve first-pass recanalization in stroke by effectively removing all types of neurovascular clots from a
In the Sheraton New York Times Hotel, 811 7th Avenue, W. 53rd St, New York, N.Y. 10019
Alucent Biomedical Inc. announced that it has enrolled the first patient in ACTIVATE II, an Australia-based first-in-human clinical trial to evaluate the safety and efficacy of AlucentNVS, the company’s natural vascular scaffolding device. According to the company, the ACTIVATE II trial will enroll up to 50 patients at up to
Koya Medical announced the United States commercial availability of its Dayspring active compression system for the treatment of lymphedema and venous diseases in the lower extremities. The company also announced that the Centers for Medicare & Medicaid Services (CMS) issued three new billing codes in accordance with the Healthcare Common
AngioDynamics, Inc. announced the launch of a new clinical study assessing the use of the company’s Auryon atherectomy system in the treatment of calcified lesions in below-the-knee (BTK) arteries. The company announced the commercial launch of the Auryon system in Sep. 2020. The investigator-initiated Auryon BTK study will be conducted
You can place any content here, including Advertising. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Quisque scelerisque lectus nec est feugiat, at eleifend sapien suscipit. Cras in neque ac nulla blandit auctor sed ut purus. Curabitur metus elit, tristique id auctor a, fermentum imperdiet felis. Maecenas imperdiet facilisis nibh at viverra. Pellentesque habitant morbi tristique senectus et netus et malesuada fames ac turpis egestas. Class aptent taciti sociosqu ad litora torquent per conubia nostra, per inceptos himenaeos. Cras euismod rhoncus nibh, et vestibulum justo bibendum et. Quisque sed vehicula erat. Nulla cursus a nisi a tincidunt. Curabitur pulvinar, urna quis volutpat dignissim, libero est fermentum mauris, ut rutrum metus lacus at ipsum. Donec rhoncus leo eget dolor gravida ullamcorper. Suspendisse tempus, velit condimentum hendrerit ultrices, tellus libero auctor leo, non feugiat libero dui a tellus.